Biomaterial Database

Malignant granular cell tumour with generalized metastases and polymyositis. 2001

U F Haustein

UI	MeSH Term	Description	Entries
D005260	Female		Females
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368	Aged	A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available.	Elderly
D012878	Skin Neoplasms	Tumors or cancer of the SKIN.	Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D016586	Granular Cell Tumor	Unusual tumor affecting any site of the body, but most often encountered in the head and neck. Considerable debate has surrounded the histogenesis of this neoplasm; however, it is considered to be a myoblastoma of, usually, a benign nature. It affects women more often than men. When it develops beneath the epidermis or mucous membrane, it can lead to proliferation of the squamous cells and mimic squamous cell carcinoma.	Granular Cell Myoblastoma,Myoblastoma, Granular Cell,Cell Myoblastoma, Granular,Cell Myoblastomas, Granular,Cell Tumor, Granular,Cell Tumors, Granular,Granular Cell Myoblastomas,Granular Cell Tumors,Myoblastomas, Granular Cell,Tumor, Granular Cell,Tumors, Granular Cell
D017285	Polymyositis	Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9)	Myositis, Multiple,Polymyositis Ossificans,Polymyositis, Idiopathic,Idiopathic Polymyositides,Idiopathic Polymyositis,Multiple Myositis,Myositides, Multiple,Ossificans, Polymyositis,Polymyositides,Polymyositides, Idiopathic
D017809	Fatal Outcome	Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.	Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal

Related Publications

U F Haustein

Malignant granular cell tumour.

December 1978, Indian journal of cancer,

U F Haustein

Malignant granular cell tumour with intraperitoneal dissemination.

April 1989, Histopathology,

U F Haustein

Granular cell tumour: malignant or benign?

September 2015, Singapore medical journal,

U F Haustein

Malignant granular cell tumour (granular cell myoblastoma): a case report.

December 1978, East African medical journal,

U F Haustein

Malignant granular cell tumour of the oesophagus.

August 1991, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,

U F Haustein

Malignant granular cell tumour of the mediastinum.

August 2014, The Malaysian journal of pathology,

U F Haustein

Malignant granular cell tumour of the sciatic nerve.

February 1995, Australasian radiology,

U F Haustein

Malignant oesophageal granular cell tumour: a case report.

October 2004, Pathology,

U F Haustein

Genetic portrait of malignant granular cell odontogenic tumour.

January 2003, Oral oncology,